SecBot SecBot
PRESS-RELEASE ·Filed Mar 2, 2026

ZVRA

Zevra Therapeutics
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight • Neutral

Traders should monitor the earnings release on March 9, 2026, for actual revenue, EPS, and guidance updates. No action is warranted based on this announcement alone.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
ZVRA ▲ +13.53% at T+60d
NEUTRAL call +13.53% · α vs SPY +4.20% · entry $9.09 → $10.32
Entry = T+0 close
Mar 2, 2026
via day close
T+1d
-1.98%
call -1.98% · α -1.07%
$8.91
settled 8mo ago
T+5d
+0.33%
call +0.33% · α +1.54%
$9.12
settled 8mo ago
T+20d
-3.41%
call -3.41% · α +4.53%
$8.78
settled 7mo ago
T+60d
+13.53%
call +13.53% · α +4.20%
$10.32
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Zevra Therapeutics announced it will report its fourth quarter and full-year 2025 financial results on March 9, 2026, after market close, followed by a conference call. The press release contains no actual financial results, guidance, or material data — it is solely an announcement of an upcoming earnings release.

Key Facts

  • Zevra Therapeutics will release Q4 and full-year 2025 financial results on March 9, 2026, after market close.
  • The company will host a conference call and webcast at 4:30 p.m. ET on the same day.
  • No financial results, metrics, or guidance were disclosed in this press release.
  • This is a routine earnings announcement with no material new information.

Financial Impact

No financial impact from this release — actual results not yet disclosed.

Risk Factors

  • Forward-looking statements in the release are subject to risks and uncertainties, and actual results may differ materially.
  • Lack of pre-announcement of positive results may suggest neutral or cautious expectations.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3247273
4 reports for ZVRA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ZVRA — sortable, filterable
TypeNow
Aug 17, 2026
10w ago
Insider Cluster
NEUTRAL ★ 3/10
$11.57awaiting T+60—$9.53 (−17.63%)
May 6, 2026
24w ago
8-K
BULLISH ★ 6/10
$11.00 $10.06▼ −8.59%▼ −12.42%$9.53 (−13.36%)
Apr 22, 2026
26w ago
Press Release
NEUTRAL ★ 1/10
$10.49 $12.77▲ +21.73%▲ +16.96%$9.53 (−9.15%)
Mar 2, 2026
34w ago
Press Release
NEUTRAL ★ 3/10
$9.09 $10.32▲ +13.53%▲ +4.20%$9.53 (+4.84%)
Showing 4 of 4

US Market Status

Market Closed — Opens in 5h 1m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 2, 2026